Tempe, AZ, May 17, 2018 – SDC is proud to announce that Garrick Wallstrom, Ph.D., Principal Research Biostatistician at SDC, will be presenting research on “Identification of High-efficacy Subgroups in Clinical Trials” at the 39th Annual Meeting of the Society for Clinical Trials (SCT) held in Portland, OR on May 20-23, 2018.
“In many studies, we seek to identify a subgroup of patients in which an active treatment is most effective compared to a control,” Wallstrom explains in his abstract. “Existing methods for finding such high-efficacy patient subgroups often find overly-complex subgroups and do not control the type 1 error rate, which can lead to low replication rates in future trials. This study developed and tested a novel strategy that identifies high-efficacy subgroups while controlling the type 1 error rate.”
Wallstrom’s presentation will be featured in the contributed session on Mediation and Moderation in Clinical Trials on Tuesday, May 22 at 9:15am-10:15am at the Hilton Portland & Executive Tower.
